Navigation Links
Epitomics Announces the Creation of 1000th Rabbit Monoclonal Antibody
Date:5/27/2008

BURLINGAME, Calif., May 27 /PRNewswire/ -- Epitomics, Inc., the rabbit monoclonal antibody company, announced today that it has developed its 1000th new rabbit monoclonal antibody. Each antibody has been created, tested and QC'd in house utilizing Epitomics' proprietary rabbit monoclonal antibody technology. "We are very excited to have reached this milestone in a short period of time. This demonstrated the robustness of our technology and development pipeline," said Dr. Guo-Liang Yu, President and CEO of Epitomics Inc. "While thousands of antibodies exist in the market our Rabbit Monoclonal antibody technology has allowed for the development of monoclonal antibodies that were previously only possible to develop as a polyclonal antibody if at all," said Dr. Yu, "many of the targets for which we have developed a Rabbit Monoclonal, no other monoclonal antibody had existed previously."

Epitomics is the exclusive provider of a proprietary method for making monoclonal antibodies from rabbits rather the conventional method of starting with mice. The advantages of Epitomics' rabbit monoclonal antibodies (RabMAbs(TM)) include high specificity and affinity which provide excellent results in a variety of commonly used immunoassays. "Each one of our rabbit monoclonal antibodies undergoes stringent testing in five major immunoassays including Western blotting, Immunohistochemistry, Immunofluorescence, Immunopreciptation and Flow Cytometry, before being released," said Dr. Peter Li, Senior VP of Product Development, "our rabbit monoclonals are among the most extensively characterized antibodies available." The complete list of Rabbit Monoclonals including background information and data for each antibody is available for viewing on Epitomics website.

About Epitomics

Epitomics, Inc., an emerging biotechnology company, is dedicated to developing breakthrough monoclonal antibody technology for research, diagnostic and therapeutic applications. The Company utilizes a unique and proprietary RabMAb(TM) (Rabbit Monoclonal Antibody) technology which produces antibodies with superior binding affinity and bioactivity in a wide variety of biological assays. The Company is headquartered in Burlingame, California, and operates a wholly owned subsidiary in Hangzhou, the People's Republic of China. More information about Epitomics can be found at http://www.epitomics.com


'/>"/>
SOURCE Epitomics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. NicOx Announces Departure of Damian Marron for CEO Position
2. CellCyte Genetics Corporation Announces Launch of Comprehensive Web site Powered by PRNewswire Investor Room Backend Technology
3. Favrille Announces Results from Phase 3 Registration Trial of Specifid in Patients with Follicular B-Cell Non-Hodgkins Lymphoma
4. Dragon Pharma Announces June 26, 2008 for 2008 Annual Shareholders Meeting
5. Cardium Therapeutics Announces Annual Meeting of Stockholders to be Held June 5, 2008
6. Oncolytics Biotech Inc. Announces Issuance of 9th Canadian Patent
7. Amnis Announces Release of Its Extended Depth of Field Option for The ImageStream(R) System
8. Amarin Announces Completion of the First Tranche of $60 Million Private Placement
9. AVANT Immunotherapeutics Announces Oral Presentation of CDX-110 at ASCO Annual Meeting
10. Exelixis Announces June 2 Webcast of Its ASCO Investor and Analyst Briefing
11. Biopure Announces 2008 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... ... February 09, 2016 , ... Clinovo ... free and validated Electronic Data Capture (EDC) system ClinCaptureand its new Contract Research ... West Coast 2016 Conference in San Mateo, California on February 10th and 11th. ...
(Date:2/9/2016)... ... 2016 , ... The American Academy of Thermology (AAT) has announced ... AAT Member Certification Qualification Course for Technicians via a two part webinar on July ... a detailed review of hardware, software, and camera setup/operations, aligns with the in-person member ...
(Date:2/9/2016)... ... February 09, 2016 , ... PharmApprove ... for the National Organization for Rare Disorders (NORD). Dorman will lead PharmApprove efforts ... are heard throughout the drug regulatory review process. , “Adding Diane Dorman is ...
(Date:2/9/2016)... YORK , Feb. 9, 2016 This ... analyzes the current and future prospects of the market ... this report include companies engaged in the manufacture of ... an executive summary with a market snapshot providing the ... scope of this report. This section also provides the ...
Breaking Biology Technology:
(Date:1/28/2016)... Jan. 28, 2016 Synaptics (NASDAQ: SYNA ), a ... its second quarter ended December 31, 2015. ... of fiscal 2016 increased 2 percent compared to the comparable quarter ... of fiscal 2016 was $35.0 million, or $0.93 per diluted share. ... income for the first quarter of fiscal 2016 grew 9 percent ...
(Date:1/25/2016)...  Glencoe Software, the world-leading supplier of image data ... provide the data management solution OMERO Plus for the ... Photo - http://photos.prnewswire.com/prnh/20160125/325328LOGO ... Phenotypic analysis measures the characteristics and behavior of ... states such as health and disease, the presence or ...
(Date:1/21/2016)... , January 21, 2016 ... to a new market research report "Emotion Detection and ... Others), Software Tools (Facial Expression, Voice Recognition and ... - Global forecast to 2020", published by MarketsandMarkets, ... expected to reach USD 22.65 Billion by 2020, ...
Breaking Biology News(10 mins):